Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
The American Journal of Physiology|August 1, 1997
Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjectsM A Banerji, J Lebowitz, R L Chaiken, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 1, 1995
Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDMM A Banerji, M C Buckley, R L Chaiken, et al.Diabetes Care|December 5, 1998
Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal dataR L Chaiken, M Eckert-Norton, M Bard, et al.Diabetes, Obesity & Metabolism|July 21, 2009
Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, type 2 diabetes studyL Blonde, S Dagogo-Jack, M A Banerji, et al.Kidney International|June 1, 1995
Interaction of hypertension and diabetes on renal function in black NIDDM subjectsR L Chaiken, J Palmisano, M E Norton, et al.Diabetes, Obesity & Metabolism|December 21, 2007
Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy databaseR E Pratley, A Schweizer, J Rosenstock, et al.Diabetes, Obesity & Metabolism|February 21, 2008
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylureaA J Garber, J E Foley, M A Banerji, et al.Diabetes|June 1, 1994
GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetesM A Banerji, R L Chaiken, H Huey, et al.Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2004
The combination oral and nutritional treatment of late-onset diabetes mellitus (CONTROL DM) trial resultsD M Reboussin, D C Goff, E W Lipkin, et al.Diabetologia|December 17, 2009
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) studyR A DeFronzo, M A Banerji, G A Bray, et al.Pageof 4